Why Celgene Shares Took a Step Back
Celgene saw its shares take a step back on Friday after the firm announced results from a late-stage clinical study of patients with follicular lymphoma.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 149
FDA Accepts Allergan and Paratek’s Newest Acne Treatment for Review
Paratek Pharmaceuticals saw its shares make a handy gain on Thursday after the firm announced that the FDA accepted its New Drug Application for the review of Seysara for the treatment of moderate to…
RBC Out With Top Pick Biotech Stocks to Buy for 2018
A new RBC report is reasonably positive on the biotech sector for the coming year. These eight top picks for 2018 all have the potential for big upside moves.
US Life Expectancy Fell Last Year: Official CDC Announcement
The Centers for Disease Control and Prevention (CDC) has announced that the life expectancy of Americans fell last year.
Exelixis Wins Big With FDA Approval
Exelixis saw its shares make a handy gain on Wednesday after the company received the nod from the FDA for Cabometyx tablets.
Portola Pharma Wins With FDA Approval
Portola Pharmaceuticals shares saw a handy gain on Tuesday after the company announced that it received a key approval from the FDA.
Valeant Pharmaceuticals Well on the Road to Recovery After Bausch + Lomb Distribution Deal
Valeant Pharmaceuticals shares made a spectacular crash over the course of 2015 to 2017, and it looks like they may now be on the path to recovery.
Tax Reform Stocking Stuffer: Pfizer Dividend Hike & Much Larger Stock Buyback
Pfizer has just raised its payout by about 6% and more than doubled what it already had on its buyback plans.
FDA Accepts Teva Pharma’s BLA for Migraine Drug
Teva Pharmaceutical Industries kicked off the week by announced an FDA for its treatment for migraines.
Analyst Sees 3 Red-Hot Medical Technology Stocks as Huge 2018 Buys
These three red-hot companies continue to dominate their specific spheres of the medical technology world, and their stocks have had outstanding runs.
Pfizer Headed for New High After FDA Nod for Joint Disease Treatment
Shares of Pfizer appeared to be headed for a new high after the company announced that the FDA had approved its treatment for adult patients with active psoriatic arthritis.
Teva Pharmaceuticals: Happy Holidays, You’re Fired
Another company has decided that the best time to fire a large number of people is just before the holidays.
Investors Can’t Seem to Make Up Their Minds on Teva’s Restructuring
Teva Pharmaceutical Industries shares turned south on Wednesday after the company said that it would be announcing its restructuring plan on Thursday.
Bluebird Bio Stumbles Over Secondary Offering
Bluebird Bio saw its shares dip on Wednesday after the firm announced the pricing of a secondary offering of more than 3 million shares.
Why Cellectis Is Winning Big With Its Pfizer Partnership
Cellectis saw its shares make a handy gain early on Wednesday after the firm announced preliminary data from its two Phase 1 studies in conjunction with Pfizer.